Evaxion A/S to Present New Target Validation Data for EVX-04 at ASH 2026 Meeting

Evaxion A/S said it will present new target-validation data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia, at the ASH Annual Meeting and Exposition in New Orleans on December 12–15, 2026. The article excerpt provides no results or other details about the data.